VIVIMED LABS LIMITED Share Price
VIVIMED LABS LIMITED Share Price Today
As of 5 Jul 2026, VIVIMED LABS LIMITED share price is ₹5.79. The stock opened at ₹5.76, compared to its previous close of ₹5.73. During today's trading session, VIVIMED LABS LIMITED share price moved in the range of ₹5.73 to ₹5.97, with an average price of ₹5.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹5.15 and a high of ₹29.40. On the performance front, VIVIMED LABS LIMITED share price has declined by 61.71% over the last six months and is down 78.23% on a year-on-year basis.
VIVIMED LABS LIMITED Returns Calculator
VIVIMED LABS LIMITED Shareholder Returns
VIVIMED LABS LIMITED Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
VIVIMED LABS LIMITED Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹116.27 | ₹149.07 | ₹187.10 | ₹237.29 |
| Other Income | ₹4.37 | ₹9.98 | ₹0.97 | ₹1.27 |
| Total Revenue | ₹120.64 | ₹159.05 | ₹188.07 | ₹238.56 |
| Total Expenses | ₹152.49 | ₹204.87 | ₹518.72 | ₹303.39 |
| Profit Before Tax | -₹31.85 | -₹45.82 | -₹330.65 | -₹64.83 |
| Tax | ₹0.11 | -₹0.38 | -₹2.12 | ₹2.82 |
| Profit After Tax | -₹31.96 | -₹45.45 | -₹328.54 | -₹67.65 |
| EPS - Basic | -₹3.85 | -₹5.48 | -₹39.62 | -₹8.16 |
| EPS - Diluted | -₹3.74 | -₹5.32 | -₹38.46 | -₹7.92 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹31.50 | -₹45.82 | -₹330.65 | -₹64.28 |
| Income before WC changes | -₹8.33 | -₹23.45 | -₹186.34 | -₹6.23 |
| Change in Assets | ₹6.62 | -₹5.24 | ₹170.80 | ₹22.20 |
| Change in Liabilities | ₹0.05 | ₹4.60 | ₹50.86 | ₹11.58 |
| Change in WC | ₹6.67 | -₹0.64 | ₹221.66 | ₹33.77 |
| Cash flow from Operations | -₹1.75 | -₹23.99 | ₹35.32 | ₹27.54 |
| Cash flow from Investing | -₹4.53 | ₹28.29 | -₹4.97 | -₹16.41 |
| Cash flow from Financing | ₹4.96 | -₹6.03 | -₹33.78 | -₹10.38 |
| Total Cash Flow | -₹1.32 | -₹1.74 | -₹3.43 | ₹0.75 |
| Cash (Start of the year) | ₹2.03 | ₹3.76 | ₹7.18 | ₹6.43 |
| Cash (End of the year) | ₹0.71 | ₹2.03 | ₹3.76 | ₹7.18 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹593.28 | ₹608.33 | ₹656.06 | ₹758.75 |
| Current Assets | ₹327.56 | ₹342.58 | ₹338.99 | ₹507.27 |
| Total Assets | ₹920.84 | ₹950.91 | ₹995.05 | ₹1,266.01 |
| Current Liabilities | ₹408.20 | ₹410.33 | ₹424.09 | ₹373.39 |
| Net Current Asset | -₹80.64 | -₹67.74 | -₹85.10 | ₹133.88 |
| Non-Current Liabilities | ₹547.81 | ₹546.05 | ₹531.54 | ₹528.34 |
| Equity Capital | -₹35.17 | -₹5.46 | ₹39.42 | ₹364.29 |
| Total Equity & Liabilities | ₹920.84 | ₹950.91 | ₹995.05 | ₹1,266.01 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹103.60 | ₹136.80 | ₹176.83 | ₹218.37 |
| Other Income | ₹4.19 | ₹9.57 | ₹0.24 | ₹1.26 |
| Total Revenue | ₹107.79 | ₹146.37 | ₹177.06 | ₹219.63 |
| Total Expenses | ₹139.29 | ₹190.75 | ₹507.19 | ₹284.56 |
| Profit Before Tax | -₹31.50 | -₹44.38 | -₹330.13 | -₹64.94 |
| Tax | ₹0.00 | ₹0.00 | -₹2.12 | ₹2.82 |
| Profit After Tax | -₹31.50 | -₹44.38 | -₹328.01 | -₹67.75 |
| EPS - Basic | -₹3.80 | -₹5.35 | -₹39.56 | -₹8.17 |
| EPS - Diluted | -₹3.69 | -₹5.20 | -₹38.40 | -₹7.93 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹30.92 | -₹44.38 | -₹330.13 | -₹64.38 |
| Income before WC changes | -₹9.76 | -₹24.07 | -₹187.94 | -₹7.40 |
| Change in Assets | ₹27.09 | -₹6.76 | ₹170.80 | ₹17.70 |
| Change in Liabilities | -₹11.60 | -₹65.70 | ₹50.01 | ₹15.01 |
| Change in WC | ₹15.49 | -₹72.46 | ₹220.80 | ₹32.71 |
| Cash flow from Operations | ₹5.73 | -₹96.52 | ₹32.87 | ₹25.31 |
| Cash flow from Investing | -₹4.06 | ₹99.83 | -₹1.60 | -₹11.34 |
| Cash flow from Financing | -₹2.53 | -₹5.51 | -₹34.70 | -₹13.21 |
| Total Cash Flow | -₹0.86 | -₹2.20 | -₹3.43 | ₹0.76 |
| Cash (Start of the year) | ₹1.14 | ₹3.35 | ₹6.78 | ₹6.02 |
| Cash (End of the year) | ₹0.29 | ₹1.15 | ₹3.35 | ₹6.78 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹391.18 | ₹405.75 | ₹524.66 | ₹629.97 |
| Current Assets | ₹247.78 | ₹275.72 | ₹271.16 | ₹441.82 |
| Total Assets | ₹638.95 | ₹681.47 | ₹795.82 | ₹1,071.79 |
| Current Liabilities | ₹393.21 | ₹391.17 | ₹412.49 | ₹365.82 |
| Net Current Asset | -₹145.43 | -₹115.45 | -₹141.33 | ₹75.99 |
| Non-Current Liabilities | ₹187.26 | ₹200.89 | ₹250.02 | ₹248.69 |
| Equity Capital | ₹58.49 | ₹89.41 | ₹133.31 | ₹457.27 |
| Total Equity & Liabilities | ₹638.95 | ₹681.47 | ₹795.82 | ₹1,071.79 |
About VIVIMED LABS LIMITED
Vivimed Labs Limited is an India-based company engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. The Company is primarily engaged in Pharma segment. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. Its manufacturing facilities are equipped to deliver a range of dosage delivery formats that include capsules, tablets, syrups & liquids, sprays & ointments.
VIVIMED LABS LIMITED Financial Highlights
- Revenue: VIVIMED LABS LIMITED reported revenue of ₹120.64 crore in FY25 vs ₹159.05 crore in FY24. It showed a decrease of 24.15% on a yearly basis.
- Operating Profit: VIVIMED LABS LIMITED reported an operating loss of ₹31.85 crore in FY25 vs ₹45.82 crore in FY24. It showed an increase of 30.49% on a year-on-year basis.
- Net Profit: VIVIMED LABS LIMITED reported a net loss of ₹31.96 crore in FY25 vs ₹45.45 crore in FY24. It showed an increase of 29.68% on a yearly basis.
VIVIMED LABS LIMITED Quarterly Result Highlights
- VIVIMED LABS LIMITED reported revenue of ₹15.99 crore in Dec 2025, compared with ₹20.82 crore in Sep 2025, representing a decrease of 23.20% on a quarter-on-quarter (QoQ) basis.
- VIVIMED LABS LIMITED reported an operating loss of ₹16.55 crore in Dec 2025, compared with ₹7.30 crore in Sep 2025, representing a decrease of 126.71% on a quarter-on-quarter (QoQ) basis.
- VIVIMED LABS LIMITED reported a loss of ₹16.55 crore in Dec 2025, compared with ₹7.30 crore in Sep 2025, reflecting a decrease of 126.71% on a QoQ basis.
- The earnings per share (EPS) of VIVIMED LABS LIMITED stood at ₹3.85 during Dec 2025.
Similar Stocks
FAQs on VIVIMED LABS LIMITED Share Price
What is VIVIMED LABS LIMITED share price today?
VIVIMED LABS LIMITED share price is ₹5.79 as on 03 Jul, 2026, 15:46 IST.
How has the VIVIMED LABS LIMITED share price performed in the past?
In the last 1 year, VIVIMED LABS LIMITED delivered a return of -78.23%. The VIVIMED LABS LIMITED share price hit a high of ₹29.40 and low of ₹5.15.
How much is the Mutual Fund shareholding in VIVIMED LABS LIMITED shares?
The Mutual Fund Shareholding in VIVIMED LABS LIMITED was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of VIVIMED LABS LIMITED shares ?
The 52-week high and low of VIVIMED LABS LIMITED share is ₹29.40 and ₹5.15 as of 03 Jul, 2026.
What is the market cap of VIVIMED LABS LIMITED?
The market capitalisation of VIVIMED LABS LIMITED is ₹47.92 Crores as on 03 Jul, 2026.
What are the stock symbols of VIVIMED LABS LIMITED?
The stock symbol of VIVIMED LABS LIMITED is VIVIMEDLAB on the NSE, 532660 on the BSE, and the ISIN is INE526G01021.
What was yesterday's closing price of VIVIMED LABS LIMITED shares ?
VIVIMED LABS LIMITED shares closed yesterday at ₹5.73 on NSE & ₹5.78 on BSE
How to buy VIVIMED LABS LIMITED shares?
To buy VIVIMED LABS LIMITED shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy VIVIMED LABS LIMITED shares on Holidays?
No, shares of VIVIMED LABS LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell VIVIMED LABS LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of VIVIMED LABS LIMITED?
The PE and PB ratio of VIVIMED LABS LIMITED is -1.37 and 6.31 respectively, as on 03 Jul, 2026, 15:46 IST.